These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11943081)

  • 1. Validation of transrectal ultrasonographic volumetry for orthotopic prostate tumours in mice.
    Kraaij R; van Weerden WM; de Ridder CM; Gussenhoven EJ; Honkoop J; Nasu Y; Bangma CH
    Lab Anim; 2002 Apr; 36(2):165-72. PubMed ID: 11943081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transrectal ultrasound for monitoring murine orthotopic prostate tumor.
    Kusaka N; Nasu Y; Arata R; Saika T; Tsushima T; Kraaij R; Bangma CH; Kumon H
    Prostate; 2001 May; 47(2):118-24. PubMed ID: 11340634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staging of prostate cancer. Accuracy of transrectal ultrasound enhanced by prostate-specific antigen.
    Wolf JS; Shinohara K; Narayan P
    Br J Urol; 1992 Nov; 70(5):534-41. PubMed ID: 1281724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of prostate volume measured by transrectal ultrasound and magnetic resonance imaging: is transrectal ultrasound suitable to determine which patients should undergo active surveillance?
    Weiss BE; Wein AJ; Malkowicz SB; Guzzo TJ
    Urol Oncol; 2013 Nov; 31(8):1436-40. PubMed ID: 22503576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative volumetric imaging of normal, neoplastic and hyperplastic mouse prostate using ultrasound.
    Singh S; Pan C; Wood R; Yeh CR; Yeh S; Sha K; Krolewski JJ; Nastiuk KL
    BMC Urol; 2015 Sep; 15():97. PubMed ID: 26391476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID mice.
    Sato N; Gleave ME; Bruchovsky N; Rennie PS; Beraldi E; Sullivan LD
    Cancer Res; 1997 Apr; 57(8):1584-9. PubMed ID: 9108464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship between screening by stratifying cases into groups on prostate specific antigen level and the positive rate of transrectal ultrasound guided systematic sextant prostate biopsy].
    Cao XL; Gao JP; Han G; Tang J; Hong BF
    Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(6):372-5. PubMed ID: 16638344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The digital rectal exam, prostate-specific antigen and transrectal echography in the diagnosis of prostatic cancer].
    Martínez de Hurtado J; Chéchile Toniolo G; Villavicencio Mavrich H
    Arch Esp Urol; 1995 Apr; 48(3):247-59. PubMed ID: 7538749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of prostate volume measured by transrectal and abdominal echography and its implication for the measurement of the PSA density for the diagnosis of prostate cancer].
    Rodríguez-Patrón Rodríguez R; Mayayo Dehesa T; Lennie Zucharino A; González Galán A
    Arch Esp Urol; 2002 Sep; 55(7):797-806. PubMed ID: 12380308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of prostate volume measurement using transabdominal ultrasonography for the improvement of prostate-speci fi c antigen-based cancer detection.
    Kobayashi T; Kawahara T; Nishizawa K; Ogura K; Mitsumori K; Ide Y
    Int J Urol; 2005 Oct; 12(10):881-5. PubMed ID: 16323981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced transrectal ultrasound (CE-TRUS) with cadence-contrast pulse sequence (CPS) technology for the identification of prostate cancer.
    Seitz M; Gratzke C; Schlenker B; Buchner A; Karl A; Roosen A; Singer BB; Bastian PJ; Ergün S; Stief CG; Reich O; Tilki D
    Urol Oncol; 2011; 29(3):295-301. PubMed ID: 19523857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate volumetric assessment by magnetic resonance imaging and transrectal ultrasound: impact of variation in calculated prostate-specific antigen density on patient eligibility for active surveillance program.
    Dianat SS; Rancier Ruiz RM; Bonekamp D; Carter HB; Macura KJ
    J Comput Assist Tomogr; 2013; 37(4):589-95. PubMed ID: 23863537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific antigen, digital rectal examination and transrectal ultrasonography: a meta-analysis for this diagnostic triad of prostate cancer in symptomatic korean men.
    Song JM; Kim CB; Chung HC; Kane RL
    Yonsei Med J; 2005 Jun; 46(3):414-24. PubMed ID: 15988815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Yield of ultrasonography-guided transrectal biopsy in the diagnosis of carcinoma of the prostate].
    Fernández González I; Ruiz Rubio JL; Llorente Abarca C; Aramburu González JA; Montes Díaz MJ; Herrero Payo A; Sánchez Sánchez E; Berenguer Sánchez A
    Arch Esp Urol; 1995; 48(6):587-94. PubMed ID: 7544968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum prostate specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors.
    Gleave ME; Hsieh JT; Wu HC; von Eschenbach AC; Chung LW
    Cancer Res; 1992 Mar; 52(6):1598-605. PubMed ID: 1371718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of methods of detection for prostate neoplasm].
    Zhong C; Chen M; Wan B
    Zhonghua Zhong Liu Za Zhi; 2001 Jan; 23(1):64-6. PubMed ID: 11783074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The adjunctive use of power Doppler imaging in the preoperative assessment of prostate cancer.
    Eisenberg ML; Cowan JE; Carroll PR; Shinohara K
    BJU Int; 2010 May; 105(9):1237-41. PubMed ID: 19888980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-specific antigen versus prostate-specific antigen density as predictor of tumor volume, margin status, pathologic stage, and biochemical recurrence of prostate cancer.
    Brassell SA; Kao TC; Sun L; Moul JW
    Urology; 2005 Dec; 66(6):1229-33. PubMed ID: 16360448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orthotopic tumorgrafts in nude mice: A new method to study human prostate cancer.
    Saar M; Körbel C; Linxweiler J; Jung V; Kamradt J; Hasenfus A; Stöckle M; Unteregger G; Menger MD
    Prostate; 2015 Oct; 75(14):1526-37. PubMed ID: 26074274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer. Mortality and morbidity after non-curative treatment with aspects on diagnosis and treatment.
    Aus G
    Scand J Urol Nephrol Suppl; 1994; 167():1-41. PubMed ID: 7542397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.